Computer simulation is becoming a commonly used technique for assessing factors that affect the estimation, control, and regulation of the quality of analytical testing processes. For For readers who are encountering papers on simulation and modeling for the first time, it may be useful to have some historical perspective on applications in quality control. The use of simulation in clinical chemistry was described in this journal in the early 1970s in a landmark paper by Aronsson et al. (5) from Uppsala University in Sweden. They used computer simulation to study how the analytical performance of an automated analyzer would be affected by the design of the analytical run (number and location of calibration samples, length of analytical run, etc.). At the University of Wisconsin, Hunt and 1(6) used manually simulated sets of method-comparison data to assess the usefulness of different statistics for estimating analytical errors, and Cembrowski et al. (7) used computer-simulated control data to study the optimization and interpretation of trend-analysis techniques in QC.
Hatjimihail (1) describes a microcomputer simulation program for the evaluation and design of internal quality-control (QC) procedures. A few issues ago, Parvin (2) discussed important considerations in the design of simulation programs to properly characterize the detection of persistent analytical errors. Ehrmeyer et al. (3) have provided an ongoing series of computer simulation studies for assessing the performance of external proficiency testing schemes, and Bennett et al. (4) have recently expanded the application to an alternative proficiency testing approach.
For readers who are encountering papers on simulation and modeling for the first time, it may be useful to have some historical perspective on applications in quality control. The use of simulation in clinical chemistry was described in this journal in the early 1970s in a landmark paper by Aronsson et al. (5) from Uppsala University in Sweden. They used computer simulation to study how the analytical performance of an automated analyzer would be affected by the design of the analytical run (number and location of calibration samples, length of analytical run, etc.). At the University of Wisconsin, Hunt and 1(6) used manually simulated sets of method-comparison data to assess the usefulness of different statistics for estimating analytical errors, and Cembrowski et al. (7) used computer-simulated control data to study the optimization and interpretation of trend-analysis techniques in QC.
In 1976, the Uppsala and Wisconsin groups began collaborative work to study more thoroughly the factors affecting the performance of internal QC procedures in clinical chemistry (8) . An interactive computer QC simulation program was developed by Groth et al. (9) to provide a tool for investigating the many factors affecting the performance of QC procedures. With the availability of a user-friendly simulation program, the performance of QC procedures could be readily studied, resulting in a standardized assessment by use of power function graphs to describe the probability for rejecting analytical runs having different sizes of random or systematic errors (10 These changing assumptions about the nature of analytical errors are sometimes uncovered when different simulation studies provide different assessments of performance. This phenomenon has been particularly true as the assumption has changed from intermittent to persistent errors, but has also been seen for other assumptions such as the shape of the error distribution.
Readers may find it confusing when they encounter differences, or apparent discrepancies, in estimates of performance. For example, Hatjimihnil (1) illustrates that when errors occur between runs or within a run, instead of at the beginning of a run, the error detection capability of Westgard rules is reduced. Parvin (2)has determined that the average run length for detection of a 1.5-s systematic shift by Westgard rules may be off by 10% or so (3.27 vs 2.98). Wood (20) has described a 244% increase in false alarms for Westgard rules when the error distribution is skewed (probability of false rejection increasing from 0.93% to 3.2%).
The significance of the differences observed can be considered in the same general way that the significance of analytical errors is evaluated. Are they statistically significant, meaning "real differences," and are they clinically significant, meaning "important differences"? Real differences" depend on utilizing proper modeling and simulation techniques to provide valid estimates. Connelly and Willard (28) describe some of the limitations that must be considered to provide proper and reliable estimates. "Important differences" assume valid estimates and further depend on the quality requirements and critical performance factors in the application of interests, i.e., an understanding of the "big picture." Although it is possible to assess the importance of these differences in this way, resolution of the differences usually requires clarifying the assumptions that have caused the differences. This clarification is critical because this knowledge leads to a better understanding of the analytical testing process, which in turn improves our capabilities for planning new quality systems and ultimately improves the analytical quality assurance of laboratory tests.
Clarifying Current Assumptions about Analytical Quality Assurance A critical assumption in current thinking about analytical quality assurance is that goals for precision and accuracy can be based on the stable performance of the measurement procedure, without any consideration for the performance of the QC procedure. For example, the cholesterol 3% analytical goals for allowable bias and allowable imprecision that have been set by the National Cholesterol Education Program (NCEP) assume a stable measurement procedure and do not consider the capability of the QC procedure for detecting changes from stable performance. In effect, the NCEP guidelines actually assume that QC isn't necessary, rather than assuming that the potential instability of a measurement procedure requires the performance of the control procedure to be considered as a component of the overall performance of the analytical process. Studies with quality-planning models that include QC performance challenge the adequacy of the NCEP recommendations for assuring the analytical quality needed in the clinical interpretation of cholesterol test results (29 At least 16 variables may need to be considered to optimize the cost-effectiveness of an analytical process. However, as in other analyses, we often make assumptions to reduce the number of variables and simplify the problem.
Any problem having four or more variables is still complex because the interactions of the variables cannot be viewed in our normal three-dimensional visual space. Models, or mathematical equations, become necessary to keep track of the quantitative interactions between the many variables. Because these models are quantitative, they necessarily force us to identify our assumptions and clarify our thinking about the nature of analytical errors and the performance of analytical processes. Simulation then becomes a useful technique to study the behavior of the models and understand the importance of our assumptions. Assumptions that have a critical impact on practical decisions for the management and operation of analytical processes need to be thoroughly studied and investigated. The aim of quality control is to provide quality that is satisfactory, e.g., safe, adequate, dependable, and economical. The overall system involves integrating the quality aspects of several related steps including the proper specification of what is wanted; design of the product or service to meet the requirements; production or installation to meet the full intent of the specifications; inspection to determine whether the resulting product or service conforms to the applicable specification; and review of usage to provide for revision of specification. Effective utilization of these technologies and activities is an essential element in the economic control of quality.
These goals provide fundamental guidance for the development of the systems for analytical quality assurance needed today to guarantee that laboratory test results achieve the necessary quality.
de Verdier emphasizes the importance of understanding the quality that is required and the importance of quality plRnning and process design for achieving the required quality in a cost-effective manner. The need to define quality requirements was well recognized by Scandinavian clinical chemists, after an earlier NORDKEM project on assessing quality requirements, which was organized by H#{248}rder (36) . Others, notably Hyltoft Petersen and H#{248}rder (37), Frazer et al. (38) , and Linnet (39),
have been developing models to define quality requirements and describe the relationship between those requirements and analytical performance specifications.
Currently, a new NOROKEM project, headed by de Verdier, is aimed at developing practical guidelines for implementing quality specifications in laboratory medicine (40).
Practical guidelines for assuring quality in the routine operation of analytical processes are the ultimate goal or the "big picture" that we are striving for. Unfortunately, this picture currently resembles a jigsaw puzzle that will require considerable time and effort for identifying and assembling the pieces. Simulation and modeling are important tools for learning about the pieces, understanding how they fit together, and formulating the picture.
Although for cost-effective analytical quality assurance.
